Lupin Ltd. Opens Strong with Significant Gap Up, Reflecting Positive Market Sentiment

Opening Price Surge and Intraday Performance

The stock opened sharply higher, registering a gain of 5.67% at the outset of trading, a notable jump compared to its previous close. This gap up was accompanied by an intraday high that matched the opening surge, with Lupin reaching ₹2,249.3, marking a fresh 52-week peak. The day’s performance saw the stock outperform its sector by 0.92%, while the Pharmaceuticals & Drugs sector itself gained 3.19% on the day.

In comparison to the broader market, Lupin’s 1-day gain of 3.77% outpaced the Sensex’s 3.02% rise, signalling relative strength. Over the past month, Lupin has delivered a 4.78% gain, contrasting with the Sensex’s decline of 1.90%, further highlighting the stock’s resilience and positive momentum in recent weeks.

Technical Indicators and Moving Averages

Lupin is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment suggests a robust upward trend across multiple timeframes. The daily moving averages indicate a bullish stance, reinforcing the strength of the current price action.

Weekly technicals present a mixed picture: the MACD is bullish, while the KST indicator also supports upward momentum. However, monthly indicators such as MACD and KST show mild bearishness, and Bollinger Bands suggest sideways movement on a monthly scale. The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, indicating a balanced momentum without overbought or oversold extremes.

Trend Reversal and Market Context

After two consecutive days of decline, Lupin’s price action reversed decisively with today’s gap up, signalling a potential shift in short-term sentiment. The stock’s ability to open significantly higher and sustain gains throughout the session points to renewed buying interest and a positive reassessment by market participants.

The Pharmaceuticals & Biotechnology sector’s overall gain of 3.19% today provides a supportive backdrop, with Lupin’s outperformance reflecting its relative strength within the industry. The stock’s market cap grade remains at 1, indicating a large-cap status with stable market capitalisation metrics.

Mojo Score and Rating Update

Lupin Ltd. holds a Mojo Score of 74.0, reflecting a positive overall assessment of its financial health, valuation, and technical outlook. The Mojo Grade was recently adjusted from Strong Buy to Buy on 28 Jan 2026, indicating a slight moderation in the rating while maintaining a favourable stance. This change suggests a recalibration of expectations without detracting from the stock’s underlying strengths.

The stock’s day change of 3.77% and its ability to establish a new 52-week high today reinforce the positive momentum underpinning the current market valuation.

Gap Up Implications and Momentum Sustainability

The significant gap up at the open is often interpreted as a strong bullish signal, reflecting overnight developments or positive sentiment carried into the trading session. Lupin’s ability to maintain the elevated price level throughout the day, touching its intraday high at the opening gap, suggests that the move is supported by genuine demand rather than a short-lived spike.

Given the stock’s positioning above all major moving averages and the bullish daily technical indicators, the momentum appears sustainable in the near term. However, the mild bearishness in some monthly indicators and the absence of strong signals from RSI imply that investors should monitor for potential consolidation or sideways movement following this sharp advance.

Sectoral and Market Comparison

Within the Pharmaceuticals & Biotechnology sector, Lupin’s outperformance today is notable. The sector’s 3.19% gain provides a constructive environment, but Lupin’s 3.77% rise relative to the Sensex’s 3.02% gain highlights its stronger relative performance. This differential underscores Lupin’s current appeal in the context of sectoral strength and broader market trends.

Summary of Key Metrics

To summarise, Lupin Ltd.’s trading session on 3 Feb 2026 was characterised by:

• Opening gap up of 5.67%, reaching a new 52-week high of ₹2,249.3
• Outperformance of the Pharmaceuticals & Biotechnology sector by 0.92%
• Trading above all major moving averages, signalling a strong technical setup
• Mojo Score of 74.0 with a Buy rating following a recent downgrade from Strong Buy
• Positive short-term momentum after reversing a two-day decline

These factors collectively indicate a robust market response and a positive technical environment for Lupin Ltd. as it navigates the current trading landscape.

Considerations on Gap Fill Potential

While the gap up reflects strong buying interest, the possibility of a gap fill cannot be discounted in volatile markets. However, Lupin’s sustained trading above key moving averages and the absence of immediate bearish signals on daily charts reduce the likelihood of a swift retracement to pre-gap levels. Investors and market watchers should observe intraday volume and price action for confirmation of momentum continuation or any signs of reversal.

Conclusion

Lupin Ltd.’s significant gap up opening on 3 Feb 2026, coupled with its new 52-week high and outperformance relative to sector and benchmark indices, highlights a strong positive market sentiment. Supported by bullish daily technicals and a solid Mojo Score, the stock’s price action suggests sustained momentum in the near term. The recent rating adjustment to Buy reflects a measured but favourable outlook, consistent with the observed price dynamics and sectoral trends.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →